Your browser does not support iframes.
Teva sponsors well-designed, carefully conducted clinical trials to determine the safety and effectiveness of new drugs and treatments which translate into improved clinical care. The following are the clinical trials of investigational compounds or therapies sponsored by Teva that are listed on www.clinicaltrials.gov.
Information on ongoing clinical trials that are sponsored by Teva is available to the public free of charge at www.clinicaltrials.gov. The registry contains basic information about each trial for you and/or your healthcare practitioners. This information is not intended to be a substitute for the informed medical advice or medical treatment of a healthcare professional who can determine if a specific medicine is appropriate for a particular patient. If you have questions regarding any information contained in this site, you should consult advice from a qualified healthcare professional.
Teva supports requests for expanded access programs that meet the criteria outlined in the policy.
Expanded access, also called “compassionate use", provides a pathway for patients to gain access to investigational drugs, biologics and medical devices for serious diseases or conditions.
To submit a request for an expanded access program, please complete this form and email it to ExpandedAccess@tevapharm.com. Teva will respond within 1 business day to confirm receipt of the request and to outline next steps.
This website and policy will be updated with a hyperlink or other reference to the expanded access record on clinicaltrials.gov after such record becomes active.